NCT00032097
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Clinical trial condition
Gliosarcoma
Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.
373 public trials
14 recruiting studies
Gliosarcoma trial results
NCT00003409
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
NCT00075894
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States
NCT00017264
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00157703
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00014521
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Active, Not Recruiting
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT02152982
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Katmai Oncology Group Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
Active, Not Recruiting
Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma
NCT04555577
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
NCT03115333
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +9 more
- Locations
-
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Eden Hospital Medical Center Castro Valley, California, United States
Active, Not Recruiting
Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
NCT05039281
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States